For the understanding of tumor immune evasion mechanism, immunotherapy has become an important part of tumor treatment, and immune checkpoint inhibitor therapy based on PD-1/PD-L1 antibody has become one of the standard treatment methods (Sui et al., 2018). The gene discussed is CD274; the disease is neoplasm.